Cergutuzumab amunaleukin
Product Specifications
CAS Number
1509916-03-3
Target
Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.997
Bioactivity
Cergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with immunostimulatory and anti-tumor activities for the study of solid cancers.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
037264-ML650 100 µL
Kallikrein 7, CT (KLK7, PRSS6, SCCE, Kallikrein-7, Serine protease 6, Stratum corneum chymotryptic enzyme) (MaxLight 650) discontinued
Sign In for Pricing
View Details MBS1166200-01 0.02 mg (E-Coli)
Recombinant Escherichia coli Uncharacterized protein yjbT (yjbT)
Sign In for Pricing
View Details 
MBS1166200-02 0.1 mg (E-Coli)
Recombinant Escherichia coli Uncharacterized protein yjbT (yjbT)
Sign In for Pricing
View Details